Literature DB >> 21286862

Accuracy of GFR estimation by the Cockroft and Gault, MDRD, and Wright equations in Oncology patients with renal impairment.

O O Faluyi1, S P Masinghe, R L Hayward, S Clive.   

Abstract

Estimation of renal function is crucial to guidance of systemic chemotherapy. With stable creatinine levels, the glomerular filtration rate (GFR) is often estimated from a single measurement of serum creatinine. We compared accuracy of the Cockroft and Gault (C&amp;G), modifying diet in renal diseases (MDRD) and Wright estimates in Oncology patients with renal impairment. Analysis was carried out on the basis of monodentate platinum treatment as the nephrotoxic mechanism of these drugs may affect accuracy of these estimates. Sixty-two consecutive patients with stable creatinine levels who had isotopic GFR measurement of ≤ 60 ml min(-1) at a regional cancer center were reviewed. Twenty-nine were on monodentate platinum treatment. Isotopic GFR was compared with estimated GFR by the three equations. We defined three categories of estimate based on the fractional difference from isotopic GFR: 'perfect' (< 10%), 'reasonable' (≥ 10% but < 30%) and 'poor' (≥ 30%). There was a trend toward provision of more perfect estimates by the MDRD equation particularly in patients on monodentate platinum treatment. Similar numbers had poor estimates from either of these equations, particularly at extremes of body weight. The MDRD formula may be the most accurate of these equations in Oncology patients with renal impairment, particularly with monodentate platinum treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21286862     DOI: 10.1007/s12032-011-9824-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  19 in total

1.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

2.  Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.

Authors:  Mário L de Lemos; Teresa Hsieh; Linda Hamata; Adeera Levin; Ken Swenerton; Ognjenka Djurdjev; Thanh Vu; Francis Hu; James Conklin; Suzanne C Malfair Taylor
Journal:  Gynecol Oncol       Date:  2006-07-27       Impact factor: 5.482

3.  Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells.

Authors:  Hui Li; Ramon F Thali; Christy Smolak; Fan Gong; Rodrigo Alzamora; Theo Wallimann; Roland Scholz; Núria M Pastor-Soler; Dietbert Neumann; Kenneth R Hallows
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Estimation of renal function -- what is appropriate in cancer patients?

Authors:  L H Barraclough; C Field; G Wieringa; R Swindell; J E Livsey; S E Davidson
Journal:  Clin Oncol (R Coll Radiol)       Date:  2008-12       Impact factor: 4.126

6.  Long-term consequences of cis-platinum-induced renal injury: a structural and functional study.

Authors:  D C Dobyan
Journal:  Anat Rec       Date:  1985-07

7.  Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients.

Authors:  Vincent Launay-Vacher; Hassane Izzedine; Jean-Baptiste Rey; Olivier Rixe; Sophie Chapalain; Souraya Nourdine; Angelo Paci; Philippe Bourget; Gilbert Deray
Journal:  Med Sci Monit       Date:  2004-04-28

Review 8.  Oxaliplatin: a review of preclinical and clinical studies.

Authors:  E Raymond; S G Chaney; A Taamma; E Cvitkovic
Journal:  Ann Oncol       Date:  1998-10       Impact factor: 32.976

9.  Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.

Authors:  S J Harland; D R Newell; Z H Siddik; R Chadwick; A H Calvert; K R Harrap
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

10.  Improvement of the Cockcroft-Gault equation for predicting glomerular filtration in cancer patients.

Authors:  L Martin; E Chatelut; A Boneu; L Rostaing; C Roussilhes; O Caselles; P Canal
Journal:  Bull Cancer       Date:  1998-07       Impact factor: 1.276

View more
  5 in total

Review 1.  Educational review: measurement of GFR in special populations.

Authors:  Guido Filler; Misan Lee
Journal:  Pediatr Nephrol       Date:  2017-12-07       Impact factor: 3.714

2.  A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma.

Authors:  A Quinton; P Lewis; P Ali; C Morgan; G Bertelli
Journal:  Med Oncol       Date:  2013-07-18       Impact factor: 3.064

Review 3.  The validity of the modification of diet in renal disease formula in HIV-infected patients: a systematic review.

Authors:  Willemijn L Eppenga; Matthijs van Luin; Clemens Richter; Hieronymus J Derijks; Peter A G M De Smet; Michel Wensing
Journal:  J Nephrol       Date:  2013-12-20       Impact factor: 3.902

4.  Is the eGFR formula adequate for evaluating renal function before chemotherapy in patients with urogenital cancer? A suggestion for clinical application of eGFR formula.

Authors:  Jiro Uozumi; Mitsuru Noguchi; Yuji Tokuda; Shohei Tobu; Kazuma Udo; Hiroaki Kakinoki; Saya Kurata; Maki Nanri; Yuka Ichibagase; Kohei Takahara
Journal:  Clin Exp Nephrol       Date:  2014-10-04       Impact factor: 2.801

Review 5.  Individualizing pharmacotherapy in patients with renal impairment: the validity of the Modification of Diet in Renal Disease formula in specific patient populations with a glomerular filtration rate below 60 ml/min. A systematic review.

Authors:  Willemijn L Eppenga; Cornelis Kramers; Hieronymus J Derijks; Michel Wensing; Jack F M Wetzels; Peter A G M De Smet
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.